ym 529 has been researched along with Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiyama, Y; Hodohara, K; Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Sato, K; Segawa, H; Yokota, A; Yuasa, T | 1 |
1 other study(ies) available for ym 529 and Leukemia
| Article | Year |
|---|---|
The anti-leukemic efficacy of the third generation bisphosphonate ONO5920/YM529.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Diphosphonates; HL-60 Cells; Humans; Imidazoles; K562 Cells; Leukemia; Mice; Mice, SCID; Protein Prenylation; ras Proteins; Transplantation, Heterologous | 2005 |